Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Evofem Biosciences Inc (EVFM)
Evofem Biosciences Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
JTC Team Announces Presenting Company Line Up for the Virtual Investor “Ask the CEO” Conference Being Held October 24-25, 2023

- Live video webcast interactive Q&A with participating companies -

EVFM : 0.0167 (+4.37%)
GRI : 0.8200 (+2.44%)
MBRX : 0.6110 (-2.86%)
XBIO : 4.35 (+5.03%)
AREC : 1.5900 (+13.57%)
CNSP : 0.3100 (+11.51%)
NVNO : 6.47 (+3.85%)
PALI : 0.4080 (+1.49%)
Evofem to Participate in the Virtual Investor Ask the CEO Conference

/PRNewswire/ -- Evofem Biosciences, Inc., (OTCQB: EVFM) (the "Company") today announced that Saundra Pelletier, Chief Executive Officer and Amy Raskopf, Senior...

EVFM : 0.0167 (+4.37%)
Evofem Announces Padagis Will Not Seek FDA Approval to Market a Generic Version of Phexxi® Until Evofem's Phexxi Patents Expire

/PRNewswire/ -- Evofem Biosciences, Inc., (OTCQB: EVFM) today announced that Padagis Israel Pharmaceuticals Ltd. (Padagis) has withdrawn the Paragraph IV...

EVFM : 0.0167 (+4.37%)
Evofem Biosciences Successfully Amends S.P.A. with Institutional Investor

/PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) (Evofem or the "Company") today announced it has successfully negotiated and entered into a fourth...

EVFM : 0.0167 (+4.37%)
Evofem Biosciences Signs Non-Binding Letter of Intent to Enable Listing on a National Stock Exchange

/PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) (Evofem or the Company) today announced it has signed a confidential non-binding letter of intent (LOI)...

EVFM : 0.0167 (+4.37%)
Evofem Biosciences Announces Financial Results for the Second Quarter of 2023

/PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) today announced financial results for the second quarter and first half of 2023....

EVFM : 0.0167 (+4.37%)
Evofem to Participate in the Virtual Investor Summer Spotlight Series

/PRNewswire/ -- Evofem Biosciences, Inc., (OTCQB: EVFM) (the "Company") today announced that Saundra Pelletier, Chief Executive Officer, and Amy Raskopf,...

EVFM : 0.0167 (+4.37%)
Evofem Biosciences Announces 1-for-125 Reverse Stock Split

/PRNewswire/ -- Evofem Biosciences, Inc., (OTCQB: EVFM) (the "Company") today announced a 1-for-125 reverse stock split of the Company's common stock, which...

EVFM : 0.0167 (+4.37%)
Evofem Biosciences Reports Year-End 2022 Financial Results and Provides Corporate Update

/PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM), the maker of Phexxi® (lactic acid, citric acid and potassium bitartrate), has reported financial...

EVFM : 0.0167 (+4.37%)
Evofem Appoints Ivy Zhang as Chief Financial Officer and Secretary

/PRNewswire/ -- Evofem Biosciences, Inc., (OTCQB: EVFM), the maker of Phexxi® (lactic acid, citric acid and potassium bitartrate), today announced the...

EVFM : 0.0167 (+4.37%)

Barchart Exclusives

Gold: Is $2,000 a Bottom?
Gold reached a new record high in 2023 and was the only precious metal with a significant gain last year. While the $2,000 level was a technical resistance level over the past years, it has become technical support in 2024. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar